This post was originally published on this site
A Gen Z philosopher once mused, “The math isn’t mathing.”. As pharma tariffs loom, potentially 25% of higher, the U.S. drug import tax is poised to disrupt pharmaceutical trade. For CHROs and HR leaders, it means less profit margins and throttling of wages across the American workforce. These U.S. pharma levies is brewing a retention crisis on American soil that can’t be tamed. We’re not entering a shift that will reshape everything from supply chains to paychecks. CHROS can no longer afford to ignore the threat that comes with the rec
ent drug import tax. A trade shift and a $
42